Biogen to pull MS drug in Australia following encephalitus reports
Healthcare March 16, 2018 11:43 am By Cat Fredenburgh | Melbourne

Biogen said Thursday it will pull its multiple sclerosis drug Zinbryta in Australia, nearly two weeks after the biotech company issued a worldwide withdrawal of […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.